基于电话风险的低剂量CT肺癌筛查资格评估
SUMMIT研究引入电话肺癌风险评估以指导面对面低剂量CT肺癌筛查资格评估的邀请,显著提高了面对面参与者符合筛查资格的比例。但电话筛查与面对面应答的一致性在年轻人和少数族裔中较低。电话风险评估是优化筛查预约选择的高效方式,但需进一步迭代以确保公平。
要点
- 电话风险评估可提高面对面评估中符合肺癌筛查资格的比例
- 年轻人和少数族裔中电话与面对面应答一致性较低
- 需进一步优化电话评估以确保公平性
核心结论
- 电话风险评估能高效优化肺癌筛查预约选择,但需改进以保证公平。
研究设计与样本
- SUMMIT研究引入电话肺癌风险评估指导面对面筛查资格评估邀请。
主要发现
- 电话风险评估显著提高了面对面参与者符合肺癌筛查资格的比例。
- 电话筛查与面对面应答的一致性在年轻人和少数族裔中较低。
临床怎么用
- 可采用电话风险评估优化肺癌筛查预约选择,但需关注年轻人和少数族裔的一致性。
局限性
- 电话与面对面应答在年轻人和少数族裔中一致性较低,需进一步迭代。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Eligibility for lung cancer screening (LCS) requires assessment of lung cancer risk, based on smoking history alongside demographic and medical factors. Reliance on individual face-to-face eligibility assessment risks inefficiency and costliness. The SUMMIT Study introduced a telephone-based lung cancer risk assessment to guide invitation to face-to-face LCS eligibility assessment, which significantly increased the proportion of face-to-face attendees eligible for LCS. However, levels of agreement between phone screener and in-person responses were lower in younger individuals and minority ethnic groups. Telephone-based risk assessment is an efficient way to optimise selection for LCS appointments but requires further iteration to ensure an equitable approach.
引用
- Dickson JL, Hall H, Horst C, et al. Telephone risk-based eligibility assessment for low-dose CT lung cancer screening. Thorax. 2022. PMID: 35863766. doi:10.1136/thoraxjnl-2021-218634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。